The Kidney Cancer Association (KCA) is proud to present the International Kidney Cancer Symposium (IKCS: North America) held each fall and the European International Kidney Cancer Symposium (IKCS: Europe) held each spring. Both conferences are an opportunity for physicians, researchers, academics, and industry professionals from across the globe to join together and exchange ideas which will direct the future of kidney cancer research and treatment in the ultimate pursuit of a cure.

IKCS 2020 held virtually was the highest-attended symposium to date with more than 570 registered attendees – increasing attendance nearly 22% from the year prior. IKCS presenters and attendees travel from Europe, Asia, South America, and dozens of cities across the United States to participate in the symposium.

The KCA symposiums offer balanced agendas with meaningful content on topics such as emerging research, noteworthy breakthroughs, current challenges, promising treatments, and patient-focused issues. IKCS serves as an introduction to the organization’s newest class of Advanced Discovery Award and Young Investigator Award recipients, who are frequent presenters or moderators throughout the course of the symposium schedule.

Each year’s symposiums are crafted to optimize a collective opportunity for learning, discussion, mentorship, camaraderie and collaboration not only on how best to care for our patients but to ultimately move the needle toward the next discovery.

As keystone events for the Kidney Cancer Association, IKCS aligns key aspects of the organization’s mission – to be a global community and leading change through advocacy, research, and education – all in the name of serving and empowering kidney cancer patients and their caregivers.

The Kidney Cancer Association was founded in 1990 by Eugene P. Schonfeld and a small group of patients and doctors in Chicago, Illinois and has grown into an international non-profit organization. The KCA promotes scientific advances through two annual research symposia and a robust grant program, participates in legislative advocacy, and seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer.

Our vision is to be the universal leader in finding the cure for kidney cancer.

Our mission is to be a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education.